DU4475 Cells
US$ 395,00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Informações gerais
| Descrição | The DU4475 cell line is a human breast cancer cell line derived from a metastatic site. It is characterized by its aggressive nature and poor differentiation, often used in research to study the mechanisms of cancer metastasis and progression. The cell line has been utilized extensively to explore the therapeutic targets and the efficacy of anti-cancer drugs in treating highly invasive breast cancer types. Genetically, DU4475 exhibits a high level of genetic instability, which is a hallmark of many cancer cells. This feature makes it a valuable model for studying the genetic and molecular events leading to cancer development and progression. Research involving DU4475 often focuses on the pathways that regulate cancer cell growth, survival, and resistance to chemotherapy, making it a critical resource for oncological studies aiming to develop more effective cancer treatments. |
|---|---|
| Organismo | Human |
| Tecido | Breast |
| Doença | Breast carcinoma |
| Local da metástase | Skin |
| Aplicações | 3D cell culture, Immuno-oncology |
| Sinônimos | Du4475, DU-4475, Du-4475, DU 4475, Du 4475, Duke University 4475 |
Características
| Idade | 62 years |
|---|---|
| Gênero | Female |
| Etnia | European |
| Morfologia | Epithelial |
| Propriedades de crescimento | Clusters in Suspension |
Dados regulatórios
| Referência | DU4475 (Cytion catalog number 300371) |
|---|---|
| Nível de biossegurança | 1 |
| NCBI_TaxID | 9606 |
| Número de acesso do Cellosaurus | CVCL_1183 |
Dados biomoleculares
| Isoenzimas | AK-1, 1, ES-D, 1, G6PD, B, GLO-I, 2, Me-2, 2, PGM1, 1-2, PGM3, 1 |
|---|---|
| Tumorigênico | Yes, in nude mice |
| Vírus | EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV - |
| Cariótipo | Human flat-moded near-tetraploid karyotype with 12% polyploidy - 88-93<4n>xxxx, +1, +1, -5, -6, +9, -10, -10, +15, +15, -16, -16, +22, +4mar, i(1q)x2, ?add(1)(p35-36)x2, ?i(5p)x2, add(6)(p11), add(6)(p1?), del(6)(q25), add(9)(q35), del(11)(q24)x2, add(15)(p11)x2, add(17)(p1?)x2, del(21)(q22.2)x2 - sideline with -20, -20, +del(7)(p11) - gain of 1q and loss of 6q typical in breast carcinoma - resembles published karyotype |
Manuseio
| Meio de cultura | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suplementos | Supplement the medium with 15% heat-inactivated FBS |
| Subcultura | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Meio de congelamento | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelamento e cultura de células |
|
| Atmosfera de incubação | 37°C, 5% CO2, humidified atmosphere. |
| Condições de envio | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condições de armazenamento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Controle de Qualidade e Análise Molecular
| Esterilidade | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de Análise (CoA)
| Número do lote | Tipo de certificado | Data | Número de catálogo |
|---|---|---|---|
| 300371-221223 | Certificado de Análise | 23. May. 2025 | 300371 |
| 300371-020924 | Certificado de Análise | 18. Dec. 2025 | 300371 |